Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2006

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/12/2006
Quarter4
Financial Year End31/12/2006
The figureshave been audited

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/12/2006 
31/12/2005 
31/12/2006 
31/12/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
266,941
244,209
1,057,868
936,431
2Profit/(loss) before tax
-657
657
27,195
42,072
3Profit/(loss) for the period
-3,312
1,181
14,084
29,134
4Profit/(loss) attributable to ordinary equity holders of the parent
-3,680
1,012
12,481
26,902
5Basic earnings/(loss) per share (sen)
-3.44
0.95
11.67
25.98
6Proposed/Declared dividend per share (sen)
0.00
0.00
11.50
14.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)

2.9600
2.9400

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
For the current financial year ended 31 December 2006, the Board of Directors recommends a final tax exempt dividend of 15% (2005: 11.5% tax exempt dividend) on ordinary shares in issue (2005: 106,958,888) for shareholders' approval at the forthcoming Annual General Meeting. The date of the Annual General Meeting and the book closure for the final dividend payment will be announced in due course.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced26 Feb 2007  
CategoryFinancial Results
Reference NoPB-070213-52768